Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact Us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
24: Making big ideas investible and measuring impact | Dan Somers of Boundary Capital
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Latest research
Our research can still be accessed for free under MIFID II.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax enhanced research
- VCT
- EIS
- SEIS
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Yourgene Health
Life Sciences
Transformed and de-risked
19 Feb 2019
Calculus Capital (Funds)
Calculus VCT Fund
By
Dr Brian Moretta
18 Feb 2019
Calculus Capital (Funds)
Financials
Calculus EIS Fund
By
Dr Brian Moretta
07 Feb 2019
Chamberlin Plc
Industrial
Trading very difficult; forecasts lowered
By
Paul Singer
06 Feb 2019
Avacta Group plc
Life Sciences
A second wake-up call for the market
By
Dr Gregoire Pave
06 Feb 2019
The Monthly: February 2019
05 Feb 2019
Shield Therapeutics Plc
Life Sciences
Cast-iron investment
By
Dr Martin Hall
28 Jan 2019
AJ Bell
Financials
Platform for growth
By
Jason Streets
24 Jan 2019
City of London Investment Group
Financials
Solid FUM update offset by margin changes
By
Dr Brian Moretta
21 Jan 2019
Advanced Oncotherapy
Life Sciences
Important regulatory milestone: ISO approval
By
Dr Gregoire Pave
21 Jan 2019
Allergy Therapeutics plc
Life Sciences
Trading update: gaining market share
By
Dr Dorothea Hill
17 Jan 2019
Prev
1
...
28
29
30
31
32
...
52
Next
